D
Diego García-Giustiniani
Publications - 21
Citations - 1035
Diego García-Giustiniani is an academic researcher. The author has contributed to research in topics: Population & Cardiomyopathy. The author has an hindex of 8, co-authored 20 publications receiving 780 citations.
Papers
More filters
Journal ArticleDOI
Atlas of the clinical genetics of human dilated cardiomyopathy
Jan Haas,Karen S. Frese,Barbara Peil,Wanda Kloos,Andreas Keller,Rouven Nietsch,Zhu Feng,Sabine Müller,Elham Kayvanpour,Britta Vogel,Farbod Sedaghat-Hamedani,Wei Keat Lim,Xiaohong Zhao,Dmitriy Fradkin,Doreen Köhler,Simon Fischer,Jennifer Franke,Sabine Marquart,Ioana Barb,Daniel Tian Li,Ali Amr,Philipp Ehlermann,Derliz Mereles,Tanja Weis,Sarah Hassel,Andreas Kremer,Vanessa King,Emil Wirsz,Emil Wirsz,Richard Isnard,Michel Komajda,Alessandra Serio,Maurizia Grasso,Petros Syrris,Eleanor Wicks,Vincent Plagnol,Luis R. Lopes,Tenna Gadgaard,Hans Eiskjær,Mads E. Jørgensen,Diego García-Giustiniani,Martin Ortiz-Genga,María G. Crespo-Leiro,Rondal H Lekanne Dit Deprez,Imke Christiaans,Ingrid A.W. van Rijsingen,Arthur A.M. Wilde,Anders Waldenström,Martino Bolognesi,Riccardo Bellazzi,Stellan Mörner,Justo Lorenzo Bermejo,Lorenzo Monserrat,Eric Villard,Jens Mogensen,Yigal M. Pinto,Philippe Charron,Perry M. Elliott,Eloisa Arbustini,Hugo A. Katus,Benjamin Meder +60 more
TL;DR: This is to the authors' knowledge, the first study that comprehensively investigated the genetics of DCM in a large-scale cohort and across a broad gene panel of the known DCM genes and underline the high analytical quality and feasibility of Next-Generation Sequencing in clinical genetic diagnostics.
Journal ArticleDOI
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Martin Ortiz-Genga,Sofía Cuenca,Matteo Dal Ferro,Esther Zorio,Ricardo Salgado-Aranda,Vicente Climent,Laura Padron-Barthe,Iria Duro-Aguado,Juan Jiménez-Jáimez,Víctor M. Hidalgo-Olivares,Enrique García-Campo,Chiara Lanzillo,M. Paz Suárez-Mier,Hagith Yonath,Sonia Marcos-Alonso,Juan Pablo Ochoa,José L. Santomé,Diego García-Giustiniani,Jorge Rodriguez-Garrido,Fernando Dominguez,Marco Merlo,Julián Palomino,Maria Luisa Peña,Juan Pablo Trujillo,Alicia Martín-Vila,Davide Stolfo,Pilar Molina,Enrique Lara-Pezzi,Francisco E. Calvo-Iglesias,Eyal Nof,Leonardo Calò,Roberto Barriales-Villa,Juan Ramón Gimeno-Blanes,Michael Arad,Pablo García-Pavía,Lorenzo Monserrat +35 more
TL;DR: In this article, the authors demonstrate the association between truncating mutations in the Filamin C (FLNC) gene and the development of high-risk dilated and arrhythmogenic cardiomyopathies.
Journal ArticleDOI
Novel Desmin Mutation p.Glu401Asp Impairs Filament Formation, Disrupts Cell Membrane Integrity, and Causes Severe Arrhythmogenic Left Ventricular Cardiomyopathy/Dysplasia.
Francisco Bermúdez-Jiménez,Víctor Carriel,Andreas Brodehl,Miguel Alaminos,Antonio Campos,Ilona Schirmer,Hendrik Milting,Beatriz Álvarez Abril,Miguel Álvarez,Silvia López-Fernández,Diego García-Giustiniani,Lorenzo Monserrat,Luis Tercedor,Juan Jiménez-Jáimez +13 more
TL;DR: The novel DES-p.Glu401Asp mutation causes predominant inherited left ventricular arrhythmogenic cardiomyopathy/dysplasia with a high incidence of adverse clinical events in the absence of skeletal myopathy or conduction system disorders.
Journal ArticleDOI
Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.
Juan Pablo Ochoa,María Sabater-Molina,José Manuel García-Pinilla,Jens Mogensen,Alejandra Restrepo-Córdoba,Julián Palomino-Doza,Eduardo Villacorta,Marina Martinez-Moreno,Javier Ramos-Maqueda,Esther Zorio,María Luisa Peña-Peña,Pablo Elpidio García-Granja,José Rodríguez-Palomares,Ivonne J. Cárdenas-Reyes,María M. de la Torre-Carpente,Alicia Bautista-Pavés,Mohammed M Akhtar,Marcos Cicerchia,Raquel Bilbao-Quesada,Maria Victoria Mogollón-Jimenez,Joel Salazar-Mendiguchía,José M. Mesa Latorre,Blanca Arnaez,Ivan Olavarri-Miguel,Maria Eugenia Fuentes-Cañamero,Arsonval Lamounier,José María Pérez Ruiz,Vicente Climent-Payá,Inmaculada Pérez-Sánchez,Juan Pablo Trujillo-Quintero,Luis R. Lopes,Alfredo Repáraz-Andrade,Rosario Marín-Iglesias,Alejandro Rodriguez-Vilela,Maria Sandin-Fuentes,José Antonio Garrote,Alejandro Cortel-Fuster,Miguel A. López-Garrido,Ana Fontalba-Romero,Tomás Ripoll-Vera,Isabel Llano-Rivas,Xusto Fernández-Fernández,María Isidoro-García,Diego García-Giustiniani,Roberto Barriales-Villa,Martin Ortiz-Genga,Pablo García-Pavía,Perry M. Elliott,Juan R. Gimeno,Lorenzo Monserrat +49 more
TL;DR: FHOD3 is a novel disease gene in hypertrophic cardiomyopathy, accounting for approximately 1% to 2% of cases, and the phenotype and the rate of cardiovascular events are similar to those reported in unselected cohorts.
Journal ArticleDOI
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain
Diego García-Giustiniani,Michael Arad,Martin Ortiz-Genga,Roberto Barriales-Villa,Xusto Fernández,Isabel Rodríguez-García,Andrea Mazzanti,Elena Veira,Emilia Maneiro,Paula Rebolo,Ivan Lesende,Laura Cazón,Dov Freimark,Juan Ramón Gimeno-Blanes,Christine E. Seidman,Jonathan G. Seidman,William J. McKenna,Lorenzo Monserrat +17 more
TL;DR: Mutations in the converter region of β myosin heavy chain are generally associated with adverse prognosis although there are differences between mutations.